News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer AG (BAY.F) Bags Rights to Female Sex Dysfunction Drug from EndoCeutics



5/6/2010 8:04:49 AM

Pharma Times -- Bayer has signed a deal with EndoCeutics, giving the German group rights to Vaginorm, an investigational treatment for vaginal atrophy and female sexual dysfunction. Vaginorm, an intra-vaginal application of the hormone dehydroepiandrosterone, is in a Phase III clinical programme and Bayer says research has shown that one quarter to one-half of postmenopausal women suffer from vaginal atrophy, tissue changes that can cause dryness, itching, burning and painful sex.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES